
Carter Walc Pharmaceuticals Private Limited
About Carter Walc Pharmaceuticals Private Limited
Data last updated:
Carter Walc Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 01 December 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2021PTC390687.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ibraq and Ghulam Nabi Mir.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No – 1 – E Upper G/F Prop. No – 888/1, Ward No – 8 Kh No – 1151/3 Min Mehrauli, New Delhi, Delhi, India – 110030.
As per the financials filed for FY 2025, the company reported a revenue of ₹5.05 Lakh. For the same year it recorded a net loss of ₹6,140 (net margin -1.2%) and EBITDA of -₹5,932 (EBITDA margin -1.2%).
Company details
Contact details
Carter Walc Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi.
- Registered AddressFlat No – 1 – E Upper G/F Prop. No – 888/1, Ward No – 8 Kh No – 1151/3 Min Mehrauli, New Delhi, Delhi, India – 110030
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Carter Walc Pharmaceuticals Private Limited
FY 2025 filings availableCarter Walc Pharmaceuticals Private Limited reported revenue of ₹5.05 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹5,932 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹6,140 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -1.2% | |||
| Net Profit Margin | -1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Carter Walc Pharmaceuticals Private Limited, buy the company report.
Board of directors of Carter Walc Pharmaceuticals Private Limited
Carter Walc Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ibraq | Director | 01 Dec 2021 | 4 Years 11 Months | Current |
| Ghulam Nabi Mir | Director | 15 Sep 2024 | 2 Years 2 Months | Current |
Peer comparison
Carter Walc Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Drima Pharmaceuticals Private Limited | ₹5.1 Lakh (FY 2024) | -25.0% | Mumbai, Maharashtra, India | |||
| Procter Pharmaceuticals Private Limited | ₹5.08 Lakh (FY 2021) | -35.0% | Dehradun, Uttarakhand, India | |||
| Asaan Pharmaceuticals Private Limited | ₹5.08 Lakh (FY 2015) | 88.0% | Bhopal, Madhya Pradesh, India | |||
| Calvert Pharmaceuticals Private Limited | ₹5.07 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Mediction Pharmaceuticals Private Limited | ₹5.06 Lakh (FY 2020) | 39.0% | New Delhi, Delhi, India | |||
| Carter Walc Pharmaceuticals Private Limitedthis company | ₹5.05 Lakh (FY 2025) | -₹6,140 | -1.2% | New Delhi, Delhi, India | ||
| Cariox Pharmaceuticals Private Limited | ₹5.05 Lakh (FY 2024) | -16.0% | Surat, Gujarat, India | |||
| Neo Universe Pharmaceuticals Private Limited | ₹5.04 Lakh (FY 2024) | -50.0% | Bhorakalan, Haryana, India | |||
| Bitts Pharmaceuticals Private Limited | ₹5.04 Lakh (FY 2023) | Hathras, Uttar Pradesh, India | ||||
| Velsh Pharmaceuticals (OPC) Private Limited | ₹5.03 Lakh (FY 2024) | -11.0% | Lucknow, Uttar Pradesh, India | |||
| Prathyasha India Agro Pharmaceuticals Research & Promotion Private Limited | ₹5 Lakh (FY 2024) | Kottarakkara, Kerala, India |
To see the full peer comparison of Carter Walc Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Carter Walc Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Carter Walc Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Carter Walc Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Carter Walc Pharmaceuticals Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Ghulam Nabi Mir was appointed as Director on 15 Sep 2024.
Frequently asked questions
Carter Walc Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 01 December 2021 (5+ years old) and is registered under CIN U74999DL2021PTC390687.
Carter Walc Pharmaceuticals has 2 current directors:
- Ibraq - Director
- Ghulam Nabi Mir - Director
The latest financial statements of Carter Walc Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Carter Walc Pharmaceuticals is U74999DL2021PTC390687. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Carter Walc Pharmaceuticals was incorporated on 01 December 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Carter Walc Pharmaceuticals by revenue are Drima Pharmaceuticals Private Limited, Procter Pharmaceuticals Private Limited, Asaan Pharmaceuticals Private Limited, Calvert Pharmaceuticals Private Limited, Mediction Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Ghulam Nabi Mir was appointed as Director on 15 Sep 2024. Nisar Ahmad Wani ceased to be Director on 15 Sep 2024. Ibraq was appointed as Director on 01 Dec 2021.
The registered office of Carter Walc Pharmaceuticals is at Flat No – 1 – E Upper GF Prop. No – 8881, Ward No – 8 Kh No – 11513 Min Mehrauli, New Delhi, Delhi, India – 110030.
Carter Walc Pharmaceuticals operates in the business services industry, in the miscellaneous business activities segment.
Carter Walc Pharmaceuticals can be reached at its registered office: Flat No – 1 – E Upper GF Prop. No – 8881, Ward No – 8 Kh No – 11513 Min Mehrauli, New Delhi, Delhi, India – 110030.
Carter Walc Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

